Aspira Pathlab & Diagnostics Limited (BOM:540788)

BOM:540788 Revenue

In the fiscal year ending March 31, 2026, Aspira Pathlab & Diagnostics had annual revenue of 249.82M INR with 13.56% growth. Aspira Pathlab & Diagnostics had revenue of 65.22M in the quarter ending March 31, 2026, with 12.91% growth.

• Revenue: 249.82M
• Revenue Growth: +13.56%
• P/S Ratio: 5.28
• Revenue / Employee: n/a
• Employees: 141
• Market Cap: 1.32B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	249.82M	29.83M	13.56%
Mar 31, 2025	219.99M	87.94M	66.60%
Mar 31, 2024	132.05M	-12.52M	-8.66%
Mar 31, 2023	144.57M	-50.85M	-26.02%
Mar 31, 2022	195.42M	43.37M	28.52%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 29, 2026

Data Sources Report a data error